Grégoire Mignot
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · 115 works · 18,694 citations · h-index 33
Top works
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
- Calreticulin exposure dictates the immunogenicity of cancer cell death
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- Consensus guidelines for the detection of immunogenic cell death
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
- In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
- Prospects for exosomes in immunotherapy of cancer
- Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- Dual Role of Heat Shock Proteins as Regulators of Apoptosis and Innate Immunity
- The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
- T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
- Immunogenicity of anthracyclines: moving towards more personalized medicine
- FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
- Human FOXP3 and cancer